Reported Earlier, AVITA Medical Announces Leadership Transition With Cary Vance As Interim CEO And Preliminary Q3 Revenue Of $17M
Benzinga Newsdesk 1 year ago
News
Board Chairman Cary Vance appointed Interim CEOBoard member Jan Stern Reed appointed Lead Independent DirectorThird quarter 2025 preliminary revenue expected to be approximately $17 million
- Board Chairman Cary Vance appointed Interim CEO
- Board member Jan Stern Reed appointed Lead Independent Director
- Third quarter 2025 preliminary revenue expected to be approximately $17 million